A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a re ...

About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...

Driven by rising rates of high blood pressure, obesity, and other key risk factors, heart disease remains the leading cause ...

Discover how this diabetes drug is revolutionizing heart health. Learn about its surprising benefits in reducing cardiovascular risks and mortality.

A new study has found a medication already used to treat people who have type 2 diabetes and/or chronic kidney disease with added heart disease risks also helps lower their stroke and heart attack ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

While conducting the study, the researchers tracked data from more than 10,000 patients who presented with type 2 diabetes, ...

High blood pressure - also known as hypertension - can lead to severe cardiovascular disease, heart attack or stroke. Six in ...